Biotech

All Articles

Amgen reports very first stage 3 gain for $400M chronic eczema medicine

.Amgen has actually discussed (PDF) the first period 3 records on its $400 million eczema drug, link...

Biogen, UCB record stage 3 lupus win after failing earlier test

.Biogen as well as UCB's bank on developing right into period 3 astride a failed study aims to have ...

Aptadir hopes brand-new RNA inhibitors may turn around difficult cancers cells

.Italian biotech Aptadir Rehabs has launched along with the assurance that its own pipeline of precl...

Wave surfs DMD excellence to regulators' doors, sending stockpile

.Surge Life Sciences has satisfied its own target in a Duchenne muscular dystrophy (DMD) research st...

Sanofi picks brand-new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma fol...

Achilles droplets tissue therapy plan, braces for discharges after missing 'commercial viability' targets

.Achilles Therapeutics has torn up its technique. The British biotech is actually stopping work on i...

Aligos declares stage 2 MASH win, reducing liver body fat up to 46%

.Aligos Therapeutics is actually advertising a midstage gain in metabolic-dysfunction affiliated ste...

Basilea credit ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job creating brand-new antifungals has actually gotten a considerable boost...

Capricor offers Europe civil liberties to late-stage DMD treatment for $35M

.Possessing presently gathered up the USA civil liberties to Capricor Rehabs' late-stage Duchenne mu...

FDA scraps adcomm for Applied's rare condition drug

.After pushing back the selection meeting for Applied Therapies' metabolic ailment medication govore...